Contact DMCA Privacy

Robuta

https://pubmed.ncbi.nlm.nih.gov/31074636/
Veliparib: a new therapeutic option in ovarian cancer?
The role of poly ADP ribose polymerase inhibitors in ovarian cancer is rapidly evolving. Three different poly ADP ribose polymerase inhibitors (olaparib,...
a newovarian cancerveliparibtherapeuticoption